Zimmer Biomet Holdings Inc (NYSE:ZBH) over-valued by 7%
| Website | http://www.zimmerbiomet.com/ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Fiscal Year End | Dec 31, 2021 |
| Market Cap | $34,557,976,576 |
| Beta | 1.330391 |
| Average Volume | $1,117,272 |
| Last Dividend | 0.96% |
| Price on May 5, 2022 | $115.03 |
| Autochartist™ Valuation | $106.81 |
| Conclusion |
7% over-valued |
| Download Report |
